Acorda, FDA Agree on Study Design
Houston Chronicle - Houston,TX,USA
Fampridine-SR is a sustained-release tablet form of the drug fampridine, which has been shown in lab studies to improve communication between damaged nerves ...
See all stories on this topic

Acorda Therapeutics Enters Deal With FDA On Special Protocol ...
Trading Markets - Los Angeles,CA,USA
... with the US Food and Drug Administration on a Special Protocol Assessment for a second Phase 3 trial of Fampridine-SR in Multiple Sclerosis or MS. ...
See all stories on this topic

Market Report -- In Play (ACOR)
MSN Money - USA
Acorda Therapeutics and FDA reach agreement on Special Protocol Assessment for second Phase 3 study of Fampridine-SR in Multiple Sclerosis Co announces that ...
See all stories on this topic

Acorda Therapeutics says FDA agrees on MS drug trial design
Reuters - USA
... Research said the US health regulators cleared the way for a second late-stage trial of its experimental multiple sclerosis drug, Fampridine-SR. ...
See all stories on this topic